Germline genome editing: Moratorium, hard law, or an informed adaptive consensus?


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 9 9 2021
pubmed: 10 9 2021
medline: 15 12 2021
Statut: epublish

Résumé

With the development of practical means of human germline genome editing (HGGE) in recent years, there have been calls for stricter regulation and oversight over HGGE interventions with potential for heritable changes in the germline. An international moratorium has been advocated. We examine the practicality of such a proposal, as well as of a regulation through the "traditional" mechanisms of international and municipal laws. We argue that these mechanisms are unlikely to achieve their intended objectives and that the better approach is to engage the international community of stakeholders, researchers, scientists, clinicians, and other workers directly involved in the field in working toward the development of an "informed adaptive consensus". We offer suggestions as to how this may be achieved and how existing indirect levers of regulation may be harnessed toward this end.

Identifiants

pubmed: 34499642
doi: 10.1371/journal.pgen.1009742
pii: PGENETICS-D-21-00795
pmc: PMC8428541
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009742

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Genet. 2000 Nov;58(5):364-6
pubmed: 11140835
BMC Med Ethics. 2015 Sep 04;16:58
pubmed: 26337535
PLoS Genet. 2021 Sep 9;17(9):e1009741
pubmed: 34499641
CRISPR J. 2019 Jun;2:134-142
pubmed: 31225756
Hugo J. 2014 Dec;8(1):3
pubmed: 27090251
Nature. 2019 Mar;567(7747):165-168
pubmed: 30867611
Nat Genet. 2003 Jun;34(2):115-6
pubmed: 12776103

Auteurs

Terry Kaan (T)

The University of Hong Kong, Hong Kong, China.

Vicki Xafis (V)

National University of Singapore, Singapore, Singapore.

G Owen Schaefer (GO)

National University of Singapore, Singapore, Singapore.

Yujia Zhu (Y)

National University of Singapore, Singapore, Singapore.

Markus K Labude (MK)

National University of Singapore, Singapore, Singapore.

Ruth Chadwick (R)

Cardiff University, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH